(BNP) - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000131104
Stock: Banking, Loans, Investments, Insurance, Advisory
Total Rating 49
Risk 25
Buy Signal -0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 30.5% |
| Relative Tail Risk | -1.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 22.33 |
| Character TTM | |
|---|---|
| Beta | 0.304 |
| Beta Downside | 0.648 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.82% |
| CAGR/Max DD | 1.24 |
EPS (Earnings per Share)
Revenue
Description: BNP March 04, 2026
BNP Paribas SA (BNP) is a diversified banking and financial services company operating globally. The companys operations are structured into three main divisions: Corporate & Institutional Banking; Commercial, Personal Banking & Services; and Investment & Protection Services.
The Corporate & Institutional Banking division focuses on capital markets, investment banking, and advisory services for corporate and institutional clients. This sector of banking often involves complex financial instruments and large-scale transactions.
The Commercial, Personal Banking & Services division provides traditional retail banking services, including accounts, loans, and insurance. Retail banking is characterized by a broad customer base and a focus on everyday financial needs.
The Investment & Protection Services division offers protection, savings, investment, and real estate services. This segment caters to individuals and institutions seeking wealth management and asset protection solutions.
BNP Paribas SA, founded in 1822, is headquartered in Paris, France. For a more comprehensive analysis of BNP Paribas financial performance and market position, continue your research on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 19.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 3.76 > 1.0 |
| NWC/Revenue: -388.5% < 20% (prev -535.5%; Δ 147.1% < -1%) |
| CFO/TA 0.01 > 3% & CFO 15.16b > Net Income 19.59b |
| Net Debt (482.25b) to EBITDA (22.45b): 21.48 < 3 |
| Current Ratio: 0.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.12b) vs 12m ago -0.92% < -2% |
| Gross Margin: 84.63% > 18% (prev 0.96%; Δ 8367 % > 0.5%) |
| Asset Turnover: 5.93% > 50% (prev 2.54%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: 0.33 > 6 (EBITDA TTM 22.45b / Interest Expense TTM 23.64b) |
Altman Z'' -1.32
| A: -0.23 (Total Current Assets 638.45b - Total Current Liabilities 1277.40b) / Total Assets 2792.98b |
| B: 0.04 (Retained Earnings 101.57b / Total Assets 2792.98b) |
| C: 0.00 (EBIT TTM 7.91b / Avg Total Assets 2773.03b) |
| D: 0.04 (Book Value of Equity 103.80b / Total Liabilities 2660.81b) |
| Altman-Z'' Score: -1.32 = CCC |
Beneish M -2.31
| DSRI: 0.46 (Receivables 52.16b/48.60b, Revenue 164.48b/69.83b) |
| GMI: 1.14 (GM 84.63% / 96.27%) |
| AQI: 1.11 (AQ_t 0.75 / AQ_t-1 0.68) |
| SGI: 2.36 (Revenue 164.48b / 69.83b) |
| TATA: 0.00 (NI 19.59b - CFO 15.16b) / TA 2792.98b) |
| Beneish M-Score: -2.31 (Cap -4..+1) = BBB |
What is the price of BNP shares?
As of March 08, 2026, the stock is trading at EUR 86.35 with a total of 3,507,910 shares traded.
Over the past week, the price has changed by -9.58%, over one month by -7.33%, over three months by +12.99% and over the past year by +23.15%.
Over the past week, the price has changed by -9.58%, over one month by -7.33%, over three months by +12.99% and over the past year by +23.15%.
Is BNP a buy, sell or hold?
has no consensus analysts rating.
What are the forecasts/targets for the BNP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.7 | 16.6% |
| Analysts Target Price | - | - |
BNP Fundamental Data Overview March 05, 2026
Market Cap USD = 114.72b (98.62b EUR * 1.1632 EUR.USD)
P/E Trailing = 8.5821
P/E Forward = 7.8555
P/S = 2.0574
P/B = 0.8071
P/EG = 2.8138
Revenue TTM = 164.48b EUR
EBIT TTM = 7.91b EUR
EBITDA TTM = 22.45b EUR
Long Term Debt = 399.65b EUR (estimated: total debt 809.21b - short term 409.56b)
Short Term Debt = 409.56b EUR (from shortTermDebt, last quarter)
Debt = 809.21b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 482.25b EUR (from netDebt column, last quarter)
Enterprise Value = 580.87b EUR (98.62b + Debt 809.21b - CCE 326.96b)
Interest Coverage Ratio = 0.33 (Ebit TTM 7.91b / Interest Expense TTM 23.64b)
EV/FCF = 47.29x (Enterprise Value 580.87b / FCF TTM 12.28b)
FCF Yield = 2.11% (FCF TTM 12.28b / Enterprise Value 580.87b)
FCF Margin = 7.47% (FCF TTM 12.28b / Revenue TTM 164.48b)
Net Margin = 11.91% (Net Income TTM 19.59b / Revenue TTM 164.48b)
Gross Margin = 84.63% ((Revenue TTM 164.48b - Cost of Revenue TTM 25.28b) / Revenue TTM)
Gross Margin QoQ = 57.91% (prev none%)
Tobins Q-Ratio = 0.21 (Enterprise Value 580.87b / Total Assets 2792.98b)
Interest Expense / Debt = 2.92% (Interest Expense 23.64b / Debt 809.21b)
Taxrate = 25.62% (1.92b / 7.49b)
NOPAT = 5.88b (EBIT 7.91b * (1 - 25.62%))
Current Ratio = 0.50 (Total Current Assets 638.45b / Total Current Liabilities 1277.40b)
Debt / Equity = 6.45 (Debt 809.21b / totalStockholderEquity, last quarter 125.51b)
Debt / EBITDA = 21.48 (Net Debt 482.25b / EBITDA 22.45b)
Debt / FCF = 39.26 (Net Debt 482.25b / FCF TTM 12.28b)
Total Stockholder Equity = 127.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.71% (Net Income 19.59b / Total Assets 2792.98b)
RoE = 15.38% (Net Income TTM 19.59b / Total Stockholder Equity 127.36b)
RoCE = 1.50% (EBIT 7.91b / Capital Employed (Equity 127.36b + L.T.Debt 399.65b))
RoIC = 1.16% (NOPAT 5.88b / Invested Capital 506.94b)
WACC = 2.70% (E(98.62b)/V(907.83b) * Re(7.04%) + D(809.21b)/V(907.83b) * Rd(2.92%) * (1-Tc(0.26)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.83%
[DCF] Terminal Value 88.43% ; FCFF base≈12.28b ; Y1≈15.15b ; Y5≈25.81b
[DCF] Fair Price = 244.8 (EV 751.50b - Net Debt 482.25b = Equity 269.25b / Shares 1.10b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 22.99 | EPS CAGR: -3.94% | SUE: 1.16 | # QB: 1
Revenue Correlation: 15.30 | Revenue CAGR: 0.97% | SUE: 1.94 | # QB: 2
EPS next Quarter (2026-06-30): EPS=3.16 | Chg7d=+0.000 | Chg30d=+0.017 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=11.83 | Chg7d=+0.017 | Chg30d=+0.494 | Revisions Net=+11 | Growth EPS=+6.6% | Growth Revenue=+6.1%
EPS next Year (2027-12-31): EPS=12.83 | Chg7d=+0.068 | Chg30d=+0.291 | Revisions Net=+9 | Growth EPS=+8.4% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.7% (Discount Rate 7.9% - Earnings Yield 11.7%)
[Growth] Growth Spread = +11.2% (Analyst 7.5% - Implied -3.7%)
P/E Trailing = 8.5821
P/E Forward = 7.8555
P/S = 2.0574
P/B = 0.8071
P/EG = 2.8138
Revenue TTM = 164.48b EUR
EBIT TTM = 7.91b EUR
EBITDA TTM = 22.45b EUR
Long Term Debt = 399.65b EUR (estimated: total debt 809.21b - short term 409.56b)
Short Term Debt = 409.56b EUR (from shortTermDebt, last quarter)
Debt = 809.21b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 482.25b EUR (from netDebt column, last quarter)
Enterprise Value = 580.87b EUR (98.62b + Debt 809.21b - CCE 326.96b)
Interest Coverage Ratio = 0.33 (Ebit TTM 7.91b / Interest Expense TTM 23.64b)
EV/FCF = 47.29x (Enterprise Value 580.87b / FCF TTM 12.28b)
FCF Yield = 2.11% (FCF TTM 12.28b / Enterprise Value 580.87b)
FCF Margin = 7.47% (FCF TTM 12.28b / Revenue TTM 164.48b)
Net Margin = 11.91% (Net Income TTM 19.59b / Revenue TTM 164.48b)
Gross Margin = 84.63% ((Revenue TTM 164.48b - Cost of Revenue TTM 25.28b) / Revenue TTM)
Gross Margin QoQ = 57.91% (prev none%)
Tobins Q-Ratio = 0.21 (Enterprise Value 580.87b / Total Assets 2792.98b)
Interest Expense / Debt = 2.92% (Interest Expense 23.64b / Debt 809.21b)
Taxrate = 25.62% (1.92b / 7.49b)
NOPAT = 5.88b (EBIT 7.91b * (1 - 25.62%))
Current Ratio = 0.50 (Total Current Assets 638.45b / Total Current Liabilities 1277.40b)
Debt / Equity = 6.45 (Debt 809.21b / totalStockholderEquity, last quarter 125.51b)
Debt / EBITDA = 21.48 (Net Debt 482.25b / EBITDA 22.45b)
Debt / FCF = 39.26 (Net Debt 482.25b / FCF TTM 12.28b)
Total Stockholder Equity = 127.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.71% (Net Income 19.59b / Total Assets 2792.98b)
RoE = 15.38% (Net Income TTM 19.59b / Total Stockholder Equity 127.36b)
RoCE = 1.50% (EBIT 7.91b / Capital Employed (Equity 127.36b + L.T.Debt 399.65b))
RoIC = 1.16% (NOPAT 5.88b / Invested Capital 506.94b)
WACC = 2.70% (E(98.62b)/V(907.83b) * Re(7.04%) + D(809.21b)/V(907.83b) * Rd(2.92%) * (1-Tc(0.26)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.83%
[DCF] Terminal Value 88.43% ; FCFF base≈12.28b ; Y1≈15.15b ; Y5≈25.81b
[DCF] Fair Price = 244.8 (EV 751.50b - Net Debt 482.25b = Equity 269.25b / Shares 1.10b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 22.99 | EPS CAGR: -3.94% | SUE: 1.16 | # QB: 1
Revenue Correlation: 15.30 | Revenue CAGR: 0.97% | SUE: 1.94 | # QB: 2
EPS next Quarter (2026-06-30): EPS=3.16 | Chg7d=+0.000 | Chg30d=+0.017 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=11.83 | Chg7d=+0.017 | Chg30d=+0.494 | Revisions Net=+11 | Growth EPS=+6.6% | Growth Revenue=+6.1%
EPS next Year (2027-12-31): EPS=12.83 | Chg7d=+0.068 | Chg30d=+0.291 | Revisions Net=+9 | Growth EPS=+8.4% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.7% (Discount Rate 7.9% - Earnings Yield 11.7%)
[Growth] Growth Spread = +11.2% (Analyst 7.5% - Implied -3.7%)